Literature DB >> 11277971

Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression.

G Yadid1, D H Overstreet, A Zangen.   

Abstract

The dopaminergic mesolimbic system has a key role in motivation and reward, and stressful stimuli appear to alter its functionality. Since stress is considered to be one of the primary factors that mediate the expression of depressive behavior, dopamine and its metabolites in the nucleus accumbens of control and Flinders Sensitive Line rats, an animal model of depression, were examined prior to and after a forced swim test. In both types of rats, the levels of dopamine metabolites markedly decreased after the forced swimming, albeit to different extents. In contrast, 60 min after the swim test, dopamine levels were elevated only in the control rats. The accumbal dopaminergic activity is discussed in relation to the behavior of 'depressed' and normal rat lines subjected to a stressful event.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277971     DOI: 10.1016/s0006-8993(00)03248-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  27 in total

1.  Repeated long separations from pups produce depression-like behavior in rat mothers.

Authors:  Maria L Boccia; Maria Razzoli; Sivaram Prasad Vadlamudi; Whit Trumbull; Christopher Caleffie; Cort A Pedersen
Journal:  Psychoneuroendocrinology       Date:  2006-11-22       Impact factor: 4.905

2.  Effects of activation and blockade of dopamine receptors on the extinction of a passive avoidance reaction in mice with a depressive-like state.

Authors:  N I Dubrovina; D V Zinov'eva
Journal:  Neurosci Behav Physiol       Date:  2009-12-11

3.  Acute stress reduces reward responsiveness: implications for depression.

Authors:  Ryan Bogdan; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2006-06-27       Impact factor: 13.382

4.  Fear induced neuronal alterations in a genetic model of depression: an fMRI study on awake animals.

Authors:  Wei Huang; Meghan E Heffernan; Zhixin Li; Nanyin Zhang; David H Overstreet; Jean A King
Journal:  Neurosci Lett       Date:  2010-12-04       Impact factor: 3.046

5.  The opposite effect of a 5-HT1B receptor agonist on 5-HT synthesis, as well as its resistant counterpart, in an animal model of depression.

Authors:  Ivan Skelin; Tomislav Kovačević; Hiroki Sato; Mirko Diksic
Journal:  Brain Res Bull       Date:  2012-04-20       Impact factor: 4.077

6.  Single prolonged stress decreases sign-tracking and cue-induced reinstatement of cocaine-seeking.

Authors:  Christopher J Fitzpatrick; Lakshmikripa Jagannathan; Elijah D Lowenstein; Terry E Robinson; Jill B Becker; Jonathan D Morrow
Journal:  Behav Brain Res       Date:  2018-08-02       Impact factor: 3.332

7.  Interrelations between monoaminergic afferents and corticotropin-releasing factor-immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural evidence for dopaminergic control of amygdaloid stress systems.

Authors:  Marina Eliava; Deniz Yilmazer-Hanke; Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-08-09       Impact factor: 4.304

Review 8.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

9.  The reward system and maternal behavior in an animal model of depression: a microdialysis study.

Authors:  Yael Lavi-Avnon; Aron Weller; John P M Finberg; Iris Gispan-Herman; Noa Kinor; Yaakov Stern; Mariana Schroeder; Vered Gelber; S Yoav Bergman; David H Overstreet; Gal Yadid
Journal:  Psychopharmacology (Berl)       Date:  2007-10-11       Impact factor: 4.530

10.  Altered gene expression and spine density in nucleus accumbens of adolescent and adult male mice exposed to emotional and physical stress.

Authors:  Brandon L Warren; Omar K Sial; Lyonna F Alcantara; Maria A Greenwood; Jacob S Brewer; John P Rozofsky; Eric M Parise; Carlos A Bolaños-Guzmán
Journal:  Dev Neurosci       Date:  2014-06-17       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.